Stock listing
OTC:SKBBY Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Stock
US listing (OTC) of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · home listing HKEX:6990
Follow Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Home listing price · HKEX:6990
$468.00 HKD +16.00 (+3.5%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:6990
- Day range
- $448.00 – $473.00 HKDOct 20, 2026
- Volume
- 709,561 sharesOct 20, 2026
- 52-week range
- $339.60 – $562.50 HKDLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:6990 · Home | $468.00 HKD | +16.00 (+3.5%) | 709,561 | $458.00 | $473.00 | $448.00 | $452.00 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · HKEX:6990 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $468.00 | +16.00 | +3.5% | $458.00 | $473.00 | $448.00 | 709,561 | |
| $452.00 | +13.60 | +3.1% | $449.80 | $470.20 | $449.00 | 909,268 | |
| $438.40 | +1.20 | +0.3% | $437.00 | $452.60 | $433.20 | 518,550 | |
| $437.20 | -12.80 | -2.8% | $450.00 | $450.00 | $431.60 | 753,642 | |
| $450.00 | +0.20 | 0.0% | $438.00 | $451.40 | $436.60 | 339,529 | |
| $449.80 | +5.20 | +1.2% | $451.00 | $458.40 | $444.80 | 396,184 | |
| $444.60 | -1.20 | -0.3% | $459.40 | $459.40 | $430.20 | 678,100 | |
| $445.80 | -22.80 | -4.9% | $461.40 | $479.40 | $445.80 | 595,069 | |
| $468.60 | -9.40 | -2.0% | $476.40 | $476.40 | $459.40 | 118,074 | |
| $478.00 | +8.20 | +1.7% | $485.00 | $485.00 | $470.00 | 217,403 | |
| $469.80 | -2.40 | -0.5% | $489.00 | $489.00 | $462.60 | 133,890 | |
| $472.20 | -14.80 | -3.0% | $500.00 | $500.00 | $459.00 | 349,283 | |
| $487.00 | +14.00 | +3.0% | $465.20 | $497.80 | $465.20 | 852,603 | |
| $473.00 | +17.80 | +3.9% | $465.00 | $479.40 | $460.60 | 685,535 | |
| $455.20 | -11.80 | -2.5% | $476.00 | $476.00 | $451.60 | 454,540 | |
| $467.00 | +1.00 | +0.2% | $466.60 | $483.80 | $463.00 | 142,625 | |
| $466.00 | -17.00 | -3.5% | $483.80 | $483.80 | $463.40 | 344,671 | |
| $483.00 | -7.20 | -1.5% | $483.20 | $497.60 | $480.40 | 392,527 | |
| $490.20 | -5.40 | -1.1% | $495.60 | $499.80 | $483.00 | 647,020 | |
| $495.60 | +34.00 | +7.4% | $475.40 | $502.00 | $472.20 | 1,579,561 | |
| $461.60 | +0.20 | 0.0% | $471.00 | $472.80 | $453.60 | 1,320,182 | |
| $461.40 | +0.80 | +0.2% | $455.00 | $467.60 | $450.00 | 479,502 | |
| $460.60 | -1.80 | -0.4% | $466.20 | $471.00 | $456.00 | 682,604 | |
| $462.40 | -18.80 | -3.9% | $481.20 | $487.60 | $456.20 | 699,464 | |
| $481.20 | +16.00 | +3.4% | $451.00 | $485.60 | $451.00 | 852,402 | |
| $465.20 | -9.20 | -1.9% | $465.20 | $473.80 | $459.80 | 656,359 | |
| $474.40 | -6.60 | -1.4% | $481.00 | $481.60 | $467.40 | 736,288 | |
| $481.00 | -7.00 | -1.4% | $488.00 | $494.00 | $478.40 | 485,320 | |
| $488.00 | -2.40 | -0.5% | $483.00 | $494.60 | $478.60 | 311,400 | |
| $490.40 | +1.00 | +0.2% | $498.40 | $498.40 | $483.00 | 255,116 | |
| $489.40 | -7.40 | -1.5% | $505.00 | $509.50 | $486.80 | 469,400 | |
| $496.80 | +3.80 | +0.8% | $489.00 | $504.00 | $489.00 | 451,756 | |
| $493.00 | +3.20 | +0.7% | $480.20 | $499.60 | $480.20 | 463,511 | |
| $489.80 | -7.40 | -1.5% | $490.00 | $504.50 | $478.00 | 588,672 | |
| $497.20 | -17.30 | -3.4% | $493.60 | $507.00 | $485.20 | 1,232,718 | |
| $514.50 | -10.00 | -1.9% | $527.00 | $531.00 | $508.00 | 681,705 | |
| $524.50 | +4.00 | +0.8% | $530.00 | $535.50 | $515.00 | 605,700 | |
| $520.50 | -3.00 | -0.6% | $535.00 | $542.50 | $517.00 | 709,172 | |
| $523.50 | +0.50 | +0.1% | $543.00 | $543.00 | $511.50 | 498,706 | |
| $523.00 | -15.00 | -2.8% | $540.00 | $543.00 | $516.50 | 545,535 | |
| $538.00 | +5.00 | +0.9% | $541.50 | $545.00 | $527.50 | 561,824 | |
| $533.00 | +9.50 | +1.8% | $540.50 | $562.50 | $525.50 | 1,574,283 | |
| $523.50 | -19.00 | -3.5% | $530.00 | $548.00 | $518.00 | 473,584 | |
| $542.50 | +20.00 | +3.8% | $530.50 | $546.50 | $517.50 | 650,430 | |
| $522.50 | +2.00 | +0.4% | $513.00 | $531.00 | $509.00 | 421,905 | |
| $520.50 | -5.00 | -1.0% | $528.50 | $528.50 | $511.00 | 403,100 | |
| $525.50 | -3.00 | -0.6% | $536.50 | $538.50 | $520.00 | 594,787 | |
| $528.50 | 0.00 | 0.0% | $519.00 | $537.50 | $519.00 | 303,900 | |
| $528.50 | 0.00 | 0.0% | $538.50 | $540.00 | $521.00 | 616,480 | |
| $528.50 | -11.00 | -2.0% | $539.50 | $552.00 | $523.00 | 604,755 | |
| $539.50 | +31.50 | +6.2% | $499.40 | $541.00 | $499.40 | 741,005 | |
| $508.00 | +16.20 | +3.3% | $480.00 | $519.00 | $480.00 | 618,201 | |
| $491.80 | +10.00 | +2.1% | $472.00 | $505.00 | $472.00 | 412,885 | |
| $481.80 | +5.00 | +1.0% | $488.80 | $490.80 | $476.20 | 368,705 | |
| $476.80 | -7.00 | -1.4% | $483.80 | $494.80 | $461.40 | 771,136 | |
| $483.80 | +2.80 | +0.6% | $495.00 | $500.50 | $473.00 | 647,390 | |
| $481.00 | -16.60 | -3.3% | $499.00 | $499.00 | $470.00 | 1,003,922 | |
| $497.60 | -10.90 | -2.1% | $509.50 | $510.50 | $476.60 | 1,605,950 | |
| $508.50 | -5.00 | -1.0% | $513.50 | $518.00 | $499.00 | 338,640 | |
| $513.50 | -0.50 | -0.1% | $517.50 | $525.00 | $506.00 | 449,996 | |
| $514.00 | -7.50 | -1.4% | $521.00 | $532.50 | $508.00 | 797,106 | |
| $521.50 | +4.50 | +0.9% | $528.00 | $530.00 | $511.50 | 635,953 | |
| $517.00 | +5.50 | +1.1% | $530.00 | $533.00 | $506.50 | 877,750 | |
| $511.50 | +7.50 | +1.5% | $509.00 | $523.00 | $494.80 | 1,005,352 | |
| $504.00 | +17.60 | +3.6% | $488.40 | $525.00 | $480.00 | 1,057,280 |
- Ticker
- OTC:SKBBY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 2, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 2, 2026
Closed $469.80 (-0.5%) on Oct 5, 2026
Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session
Sep 22, 2026
Closed $490.20 (-1.1%) on Sep 22, 2026
2026 Interim report
Sep 17, 2026
Closed $461.60 (0.0%) on Sep 18, 2026
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO
Sep 14, 2026
Closed $481.20 (+3.4%) on Sep 14, 2026
Kelun-Biotech Announces 2026 Interim Results
Aug 17, 2026
Closed $542.50 (+3.8%) on Aug 18, 2026
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
Jul 30, 2026
Closed $483.80 (+0.6%) on Jul 31, 2026
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565
Jul 27, 2026
Closed $508.50 (-1.0%) on Jul 28, 2026
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma
Jul 15, 2026
Closed $522.50 (-2.6%) on Jul 16, 2026
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
Jul 14, 2026
Closed $536.50 (+7.7%) on Jul 15, 2026
Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026
Jun 2, 2026
Closed $403.60 (-7.3%) on Jun 2, 2026
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 35 in the last 12 months · 51 in all · newest Oct 2, 2026 · oldest 2025
Where Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:6990 科倫博泰生物 · Home listing | HKEX | Hong Kong | HKD |
| OTC:SKBBY · This page | OTC | United States | USD |
Log in to ask 6ix AI your own questions about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.